A double-blind sequential comparison of doxepin with amitriptyline in depressed patients. 1972

M Toru, and M Takamizawa, and T Kariya, and K Kobayashi, and R Takahashi

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004316 Doxepin A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors. Apo-Doxepin,Aponal,Deptran,Desidox,Doneurin,Doxepia,Doxepin Hydrochloride,Doxepin Hydrochloride, Cis-Trans Isomer Mixture (approximately 1:5),Doxepin beta,Doxepin-RPh,Espadox,Mareen,Novo-Doxepin,Prudoxin,Quitaxon,Sinequan,Sinquan,Xepin,Zonalon,Apo Doxepin,ApoDoxepin,Doxepin RPh,Hydrochloride, Doxepin,Novo Doxepin
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Toru, and M Takamizawa, and T Kariya, and K Kobayashi, and R Takahashi
May 1974, Current therapeutic research, clinical and experimental,
M Toru, and M Takamizawa, and T Kariya, and K Kobayashi, and R Takahashi
October 1982, The Journal of clinical psychiatry,
M Toru, and M Takamizawa, and T Kariya, and K Kobayashi, and R Takahashi
August 1995, Acta psychiatrica Scandinavica,
M Toru, and M Takamizawa, and T Kariya, and K Kobayashi, and R Takahashi
April 1980, International journal of clinical pharmacology, therapy, and toxicology,
M Toru, and M Takamizawa, and T Kariya, and K Kobayashi, and R Takahashi
March 1996, Acta psychiatrica Scandinavica,
M Toru, and M Takamizawa, and T Kariya, and K Kobayashi, and R Takahashi
December 1990, The Journal of clinical psychiatry,
M Toru, and M Takamizawa, and T Kariya, and K Kobayashi, and R Takahashi
May 1983, The Journal of clinical psychiatry,
M Toru, and M Takamizawa, and T Kariya, and K Kobayashi, and R Takahashi
February 1972, The Medical journal of Australia,
M Toru, and M Takamizawa, and T Kariya, and K Kobayashi, and R Takahashi
May 1987, Acta psychiatrica Scandinavica,
M Toru, and M Takamizawa, and T Kariya, and K Kobayashi, and R Takahashi
January 1969, Psychosomatics,
Copied contents to your clipboard!